SCHEMBL8075929

SCHEMBL8075929

O=[C]CCC1CCCCCCC(C2CCCCCCCC2)C1

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
ALOX5 P09917 1/20 0.31
CYP1A2 P05177 1/20 0.30
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2704009 0.83 CYP1A2 (0.42) ALDH1A1HPGDCYP1A2EPHX1
SCHEMBL911042 0.83 CYP1A2 (0.42) ALDH1A1HPGDCYP1A2EPHX1
SCHEMBL96802 0.80
SCHEMBL5218136 0.75
SCHEMBL10747737 0.74 ALOX5 (0.42) ALDH1A1HPGDALOX5CYP1A2EPHX1
SCHEMBL20173820 0.72 ALDH1A1 (0.36) ALDH1A1HPGDALOX5
SCHEMBL910719 0.72
SCHEMBL10603449 0.71 CYP1A2 (0.46) ALDH1A1HPGDALOX5CYP1A2EPHX1
SCHEMBL98082 0.70
SCHEMBL99022 0.70 CYP1A2 (0.50) HPGDCYP1A2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6071895-A RETROVIRAL PROTEASES INHIBITOR; USEFUL FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS VIRAL INFECTIONS SUCH AS ACQUIRED IMMUNODEFICIENCY SYNDROME(AIDS); COMPOUND CONTAINING A CYCLIC DIAZAALKANE GROUP NARHEX LIMITED (HK) 2000-06-06 US disclosed
US-5888992-A PROTEASE INHIBITOR; VIRICIDE NARHEX LIMITED (HK) 1999-03-30 US disclosed